Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Genzyme division drives sales growth at Sanofi

Country: France

Sanofi SA reported revenue of €9.4 billion in the 2015 second quarter, up by 16.1% on a reported basis, driven in part by sales from its Genzyme unit and a strengthening of the dollar against the euro. At constant exchange rates, the increase was 4.9%.

Read more

Pharming boosted by Ruconest sales

Country: Netherlands

Pharming Group NV more than doubled its revenue in the 2015 first-half as sales of Ruconest, its treatment for hereditary angioedema (HAE) gained momentum following US regulatory approval in July 2014. The approval came nearly four years after the drug was authorised in Europe.

Read more

AZ continues the transition to growth

Country: United Kingdom

Read more

GSK expects return to earnings growth in 2016

Country: United Kingdom

Read more

MorphoSys confirms 2015 guidance

Country: Germany

Read more

Malaria vaccine passes first regulatory hurdle

Country: United Kingdom

Read more

Oxford Nanopore raises ÂŁ70 million in equity

Country: United Kingdom

Read more

Roche confirms 2015 sales outlook

Country: Switzerland

Read more

Shire takes second quarter hit

Country: Ireland

Read more

Novartis results boosted by Sandoz division

Country: Switzerland

Read more

New structure for Sanofi

Country: France

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

The sky is the limit as Celgene invests in Juno

subscribers only

Highlights of the July-August 2015 MedNous issue

The July-August 2015 MedNous features:

Latest Mednous cover
  • Business Strategy
    Antibodies for infectious disease
    Interview with Humabs
  • Public Policy
    Controversy over the ‘hospital exemption’
  • Commentary
    The new deal in immunotherapy: Celgene and Juno
    By Stéphane Boissel
  • Commentary
    Has the UK helped Biotech SMEs?
    by Jon Rees
  • Quarterly stock market review
    Big gains for eight European biotechs

The latest MedNous journal. Subscribe to download.